This exploratory, open - label, phase 1 - anti - HLA anti body levels and improve transplantation rates.

本项前瞻性 、 开放性、前1 、 2阶段、单中心的研究验证静注免疫球蛋白联用利妥昔单抗是否能够减少抗HLA抗体 的水平和提高移植成功率.

互联网

Please do not expect a big increase in your Phase 1 score, however.

但是不要期望你阶段1的分数会有大的增长.

互联网

You will probably have lower sensitivity and specificity scores than you had in Phase 1.

你可能得到比阶段1中要低得敏感度和专一度.

互联网